Ionis Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:IONS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 35.89 M30.8 M-274.37 M-307.51 M-500.95 M-268.58 M -910.63 M Cash from investing activities 274.48 M194.91 M-262.64 M-214.13 M-134.03 M-277.78 M 88.58 M Cash from financing activities -596.61 M245.93 M-55.3 M644.08 M478.06 M675.84 M 730.9 M Free cash flow 35.89 M30.8 M-274.37 M-307.51 M-500.95 M-268.58 M -910.63 M

News

Reasons Why Investors Should Consider Betting on PTC Stock Now

Stock Market Mixed As Oil Prices Jump; Delta Air, SK Hynix In Focus: Weekly Review

Strength in Chipmakers Boosts Stock Indexes

Alnylam: Unexpected Rival Trial Failure Improves Core TTR Franchise Outlook (ALNY)

Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That - TipRanks.com

Stocks Climb on Strength in Chipmakers

AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study

Why AstraZeneca Crashed 8%, Leading Three Rivals, Including Pfizer, To Jump

Schwab strategists warn of a major market shift: The era of easy index gains is officially over

London's FTSE 100 slips as Middle East tensions persist, AstraZeneca drags

Major drugmaker loses $27 billion in market value after failed trial

Stock Market Today: S&P 500, Nasdaq 100 Futures Rise as US-Iran Exchange Strikes—Levi Strauss, AZZ, Ionis